Head-To-Head Survey: Enovis (NYSE:ENOV) & Odyssey Health (OTCMKTS:ODYY)

Odyssey Health (OTCMKTS:ODYY) and Enovis (NYSE:ENOV) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Valuation & Earnings

This table compares Odyssey Health and Enovis”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Odyssey Health	N/A	N/A	N/A	N/A	N/A
Enovis	$2.25 billion	0.67	-$1.18 billion	($19.26)	-1.35

Odyssey Health has higher earnings, but lower revenue than Enovis.

Institutional & Insider Ownership

98.5% of Enovis shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Odyssey Health and Enovis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Odyssey Health	N/A	N/A	N/A
Enovis	-47.96%	12.03%	4.91%

Analyst Ratings

This is a summary of current ratings and target prices for Odyssey Health and Enovis, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Odyssey Health	0	0	0	0	0.00
Enovis	1	1	8	0	2.70

Enovis has a consensus price target of $42.00, indicating a potential upside of 61.02%. Given Enovis’ stronger consensus rating and higher probable upside, analysts clearly believe Enovis is more favorable than Odyssey Health.

Summary

Enovis beats Odyssey Health on 8 of the 9 factors compared between the two stocks.

About Odyssey Health

Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.